ErectiStim also combines bioelectrical therapy for improving muscle performance. It is our belief that BOTH are essential for long-term erectile dysfunction recovery.
Elevated myostatin levels have been implicated in numerous muscle disorders including penile erectile dysfunction. In these conditions, inhibition of the myostatin pathway represents an alternative strategy to improve functional outcomes. Preclinical data that support this approach clearly demonstrate the potential for blocking the myostatin pathway. Follistatin has emerged as a powerful antagonist of myostatin that can increase penile and other muscle mass and strength. Follistatin was first isolated from the ovary and is known to suppress follicle-stimulating hormone. ErectiStim has precise bioelectric signaling sequences that have demonstrated an ability to control release of the follistatin protein in penile tissue on demand.